Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Anesth Analg ; 77(5): 954-62, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8214734

ABSTRACT

To elucidate the effects of nitrous oxide (N2O) on left ventricular (LV) pump performance and contractility, 28 patients undergoing coronary artery bypass graft surgery were studied, of whom 15 had depressed global LV function at preoperative catheterization. Transesophageal echocardiography and simultaneous hemodynamic measurements were used to assess LV preload, afterload, and systolic performance during inhalation of 100% oxygen (O2) and 60% N2O:40% O2. Systolic function indices were expressed as a percent of the predicted value for observed end-systolic stress to provide estimates of LV contractility. In the entire study population, N2O reduced pump performance (cardiac index 2.4 +/- 0.8 to 2.2 +/- 0.6 L.min-1 x m-2; P < 0.02). Heart rate and mean arterial pressure were reduced (67 +/- 13 to 64 +/- 13, P < 0.01, and 87 +/- 9 to 80 +/- 15, P < 0.005) as were left and right ventricular stroke work index. Preload, as measured by end-diastolic stress, was unchanged but afterload, as measured by end-systolic stress, tended to decrease (88 +/- 31 to 78 +/- 28, P = 0.053). In the 13 patients with normal preoperative LV function, mean arterial pressure and LV stroke work index decreased significantly (91 +/- 8 to 84 +/- 14, P < 0.04, and 40 +/- 13 to 34 +/- 10, P < 0.04, respectively) and end-systolic stress tended to decrease (P = 0.054).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Coronary Artery Bypass , Coronary Disease/surgery , Myocardial Contraction/drug effects , Nitrous Oxide/pharmacology , Stroke Volume/physiology , Ventricular Function, Left/drug effects , Aged , Aged, 80 and over , Coronary Disease/physiopathology , Female , Humans , Male , Middle Aged , Myocardial Contraction/physiology , Ventricular Function, Left/physiology
2.
J Oral Maxillofac Surg ; 46(12): 1048-50, 1988 Dec.
Article in English | MEDLINE | ID: mdl-3057146

ABSTRACT

In a double-blind, randomized plan of drug administration, nalbuphine, fentanyl, and a placebo were compared for efficacy in sedation and analgesia during third molar removal. Fifty-eight patients participated in this study. Using accepted intravenous sedation and surgical techniques, fentanyl and nalbuphine were found to be better than placebo for anxiety and pain control in third molar surgery. Fentanyl had a longer duration of pain relief postoperatively than did nalbuphine. The study confirmed the need for a narcotic supplement to sedation techniques for third molar surgery.


Subject(s)
Analgesics , Fentanyl/therapeutic use , Molar, Third/surgery , Morphinans/therapeutic use , Nalbuphine/therapeutic use , Tooth Extraction , Tooth, Impacted/surgery , Clinical Trials as Topic , Diazepam , Double-Blind Method , Humans , Male , Patient Compliance , Placebos , Preanesthetic Medication , Random Allocation
3.
Eur J Pharmacol ; 121(2): 173-9, 1986 Feb 18.
Article in English | MEDLINE | ID: mdl-2870927

ABSTRACT

The effect of (+/-)-cis-2,3-piperidine dicarboxylic acid [+/-)-cis-2,3-PDA) on formation of cyclic GMP by immature (7-8 day) rat cerebellar slices has been studied. Using magnesium free medium containing the phosphodiesterase inhibitor isobutylmethylxanthine (IBMX), (+/-)-cis-2,3-PDA behaves as an NMDA partial agonist. Thus in this medium, (+/-)-cis-2,3-PDA stimulates cyclic GMP formation, an effect completely blocked by the potent, specific NMDA antagonist (+/-)-2-amino-7-phosphonoheptanoic acid [+/-)-APH) with a Ki = 17.1 microM. The production of cyclic GMP by the full agonist (+/-)-trans-2,3-PDA, was also blocked by (+/-)-APH, suggesting that in this preparation it activates NMDA receptors. (+/-)-trans-2,3-PDA was approximately half as potent as NMDA. By constructing dose response curves to NMDA in the presence of increasing concentrations of (+/-)-APH or (+/-)-APV, these compounds were shown to be competitive NMDA antagonists using Schild analysis.


Subject(s)
Aspartic Acid/analogs & derivatives , Cerebellum/metabolism , Cyclic GMP/biosynthesis , Pipecolic Acids/pharmacology , 2-Amino-5-phosphonovalerate , Amino Acids/pharmacology , Animals , Anticonvulsants/pharmacology , Aspartic Acid/antagonists & inhibitors , Aspartic Acid/pharmacology , Dose-Response Relationship, Drug , Female , In Vitro Techniques , Magnesium/pharmacology , Male , N-Methylaspartate , Rats , Rats, Inbred Strains , Valine/analogs & derivatives , Valine/pharmacology
5.
J Morphol ; 155(1): 1-17, 1978 Jan.
Article in English | MEDLINE | ID: mdl-73594

ABSTRACT

There are two discrete lobes comprising the armadillo submandibular gland. These two lobes can be defined grossly, histochemically and morphologically with the light and electron microscope. The minor lobe stains more intensely with PAS and AB. When viewed in the electron microscope, the secretory granules of the acinar cells within this lobe appear mucous-like. The granules of the demilune cells are slightly different in appearance. The secretory granules of the acinar cells in the major lobe contain many dense foci embedded in a fibrillar matrix, a substructure not described previously. The demilune cells of this lobe contain secretory granules with a mucous-like structure which is consistent throughout the entire lobe. As in the minor lobe, these demilune cells stain very intensely with PAS and AB.


Subject(s)
Armadillos/anatomy & histology , Submandibular Gland/ultrastructure , Xenarthra/anatomy & histology , Animals , Cytoplasmic Granules/ultrastructure , Female , Male , Mucus/metabolism , Staining and Labeling , Submandibular Gland/metabolism
8.
Am J Clin Nutr ; 20(4): 352-4, 1967 Apr.
Article in English | MEDLINE | ID: mdl-6022013
SELECTION OF CITATIONS
SEARCH DETAIL
...